 | • レポートコード：QAF27850 • 出版社/出版日：QYResearch / 2021年4月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の肺炎球菌ワクチン市場について種類別（PPSV23、PCV7/13、PCV10）、用途別（子供、大人）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・肺炎球菌ワクチン市場の概要 ・世界の主要地域別肺炎球菌ワクチン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の肺炎球菌ワクチン市場規模2016-2021：種類別（PPSV23、PCV7/13、PCV10） ・世界の肺炎球菌ワクチン市場予測2012-2027：種類別（PPSV23、PCV7/13、PCV10） ・世界の肺炎球菌ワクチン市場規模2016-2021：用途別（子供、大人） ・世界の肺炎球菌ワクチン市場予測2012-2027：用途別（子供、大人） ・肺炎球菌ワクチンのアメリカ市場規模と予測2016-2021 ・肺炎球菌ワクチンのヨーロッパ市場規模と予測2016-2021 ・肺炎球菌ワクチンの中国市場規模と予測2016-2021 ・肺炎球菌ワクチンの日本市場規模と予測2016-2021 ・肺炎球菌ワクチンの東南アジア市場規模と予測2016-2021 ・肺炎球菌ワクチンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Pfizer、GSK、MSD、Sanofipasteur、CDIBP） ・肺炎球菌ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・肺炎球菌ワクチンの市場動向・機会・課題 ・調査の結論 |
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40% in 2015.
The second place is Europe, following North America with sales market share over 18% in 2016. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share in 2013, but the consumption experienced a sharp decrease due to approval of government departments in last few years.
Market Analysis and Insights: Global Pneumococcal Vaccine Market
The global Pneumococcal Vaccine market was valued at US$ 7200.2 in 2020 and will reach US$ 7688.7 million by the end of 2027, growing at a CAGR of 1.1% during 2022-2027.
Global Pneumococcal Vaccine Scope and Market Size
The global Pneumococcal Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pneumococcal Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
PPSV 23
PCV 7/13
PCV 10
Segment by Application
Child
Adult
The Pneumococcal Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Pneumococcal Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Pfizer
GSK
MSD
Sanofipasteur
CDIBP
1 Pneumococcal Vaccine Market Overview
1.1 Pneumococcal Vaccine Product Scope
1.2 Pneumococcal Vaccine Segment by Type
1.2.1 Global Pneumococcal Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 PPSV 23
1.2.3 PCV 7/13
1.2.4 PCV 10
1.3 Pneumococcal Vaccine Segment by Application
1.3.1 Global Pneumococcal Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Child
1.3.3 Adult
1.4 Pneumococcal Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Pneumococcal Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Pneumococcal Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Pneumococcal Vaccine Price Trends (2016-2027)
2 Pneumococcal Vaccine Estimates and Forecasts by Region
2.1 Global Pneumococcal Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Pneumococcal Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Pneumococcal Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Pneumococcal Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Pneumococcal Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Pneumococcal Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Pneumococcal Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Pneumococcal Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Pneumococcal Vaccine Estimates and Projections (2016-2027)
2.4.3 China Pneumococcal Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Pneumococcal Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Pneumococcal Vaccine Estimates and Projections (2016-2027)
2.4.6 India Pneumococcal Vaccine Estimates and Projections (2016-2027)
3 Global Pneumococcal Vaccine Competition Landscape by Players
3.1 Global Top Pneumococcal Vaccine Players by Sales (2016-2021)
3.2 Global Top Pneumococcal Vaccine Players by Revenue (2016-2021)
3.3 Global Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pneumococcal Vaccine as of 2020)
3.4 Global Pneumococcal Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Pneumococcal Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Pneumococcal Vaccine Market Size by Type
4.1 Global Pneumococcal Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Pneumococcal Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Pneumococcal Vaccine Price by Type (2016-2021)
4.2 Global Pneumococcal Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Pneumococcal Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Pneumococcal Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Pneumococcal Vaccine Price Forecast by Type (2022-2027)
5 Global Pneumococcal Vaccine Market Size by Application
5.1 Global Pneumococcal Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Pneumococcal Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Pneumococcal Vaccine Price by Application (2016-2021)
5.2 Global Pneumococcal Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Pneumococcal Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Pneumococcal Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Pneumococcal Vaccine Price Forecast by Application (2022-2027)
6 North America Pneumococcal Vaccine Market Facts & Figures
6.1 North America Pneumococcal Vaccine Sales by Company
6.1.1 North America Pneumococcal Vaccine Sales by Company (2016-2021)
6.1.2 North America Pneumococcal Vaccine Revenue by Company (2016-2021)
6.2 North America Pneumococcal Vaccine Sales Breakdown by Type
6.2.1 North America Pneumococcal Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Pneumococcal Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Pneumococcal Vaccine Sales Breakdown by Application
6.3.1 North America Pneumococcal Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Pneumococcal Vaccine Sales Breakdown by Application (2022-2027)
7 Europe Pneumococcal Vaccine Market Facts & Figures
7.1 Europe Pneumococcal Vaccine Sales by Company
7.1.1 Europe Pneumococcal Vaccine Sales by Company (2016-2021)
7.1.2 Europe Pneumococcal Vaccine Revenue by Company (2016-2021)
7.2 Europe Pneumococcal Vaccine Sales Breakdown by Type
7.2.1 Europe Pneumococcal Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Pneumococcal Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Pneumococcal Vaccine Sales Breakdown by Application
7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)
8 China Pneumococcal Vaccine Market Facts & Figures
8.1 China Pneumococcal Vaccine Sales by Company
8.1.1 China Pneumococcal Vaccine Sales by Company (2016-2021)
8.1.2 China Pneumococcal Vaccine Revenue by Company (2016-2021)
8.2 China Pneumococcal Vaccine Sales Breakdown by Type
8.2.1 China Pneumococcal Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Pneumococcal Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Pneumococcal Vaccine Sales Breakdown by Application
8.3.1 China 245 Sales Breakdown by Application (2016-2021)
8.3.2 China 245 Sales Breakdown by Application (2022-2027)
9 Japan Pneumococcal Vaccine Market Facts & Figures
9.1 Japan Pneumococcal Vaccine Sales by Company
9.1.1 Japan Pneumococcal Vaccine Sales by Company (2016-2021)
9.1.2 Japan Pneumococcal Vaccine Revenue by Company (2016-2021)
9.2 Japan Pneumococcal Vaccine Sales Breakdown by Type
9.2.1 Japan Pneumococcal Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Pneumococcal Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Pneumococcal Vaccine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Pneumococcal Vaccine Market Facts & Figures
10.1 Southeast Asia Pneumococcal Vaccine Sales by Company
10.1.1 Southeast Asia Pneumococcal Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Pneumococcal Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Pneumococcal Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Pneumococcal Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Pneumococcal Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Pneumococcal Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)
11 India Pneumococcal Vaccine Market Facts & Figures
11.1 India Pneumococcal Vaccine Sales by Company
11.1.1 India Pneumococcal Vaccine Sales by Company (2016-2021)
11.1.2 India Pneumococcal Vaccine Revenue by Company (2016-2021)
11.2 India Pneumococcal Vaccine Sales Breakdown by Type
11.2.1 India Pneumococcal Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Pneumococcal Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Pneumococcal Vaccine Sales Breakdown by Application
11.3.1 India Pneumococcal Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Pneumococcal Vaccine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Pneumococcal Vaccine Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Pneumococcal Vaccine Products Offered
12.1.5 Pfizer Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Business Overview
12.2.3 GSK Pneumococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK Pneumococcal Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 MSD
12.3.1 MSD Corporation Information
12.3.2 MSD Business Overview
12.3.3 MSD Pneumococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 MSD Pneumococcal Vaccine Products Offered
12.3.5 MSD Recent Development
12.4 Sanofipasteur
12.4.1 Sanofipasteur Corporation Information
12.4.2 Sanofipasteur Business Overview
12.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sanofipasteur Pneumococcal Vaccine Products Offered
12.4.5 Sanofipasteur Recent Development
12.5 CDIBP
12.5.1 CDIBP Corporation Information
12.5.2 CDIBP Business Overview
12.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 CDIBP Pneumococcal Vaccine Products Offered
12.5.5 CDIBP Recent Development
…
13 Pneumococcal Vaccine Manufacturing Cost Analysis
13.1 Pneumococcal Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pneumococcal Vaccine
13.4 Pneumococcal Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pneumococcal Vaccine Distributors List
14.3 Pneumococcal Vaccine Customers
15 Market Dynamics
15.1 Pneumococcal Vaccine Market Trends
15.2 Pneumococcal Vaccine Drivers
15.3 Pneumococcal Vaccine Market Challenges
15.4 Pneumococcal Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Pneumococcal Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Pneumococcal Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Pneumococcal Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Pneumococcal Vaccine Sales (K Doses) by Region (2016-2021)
Table 5. Global Pneumococcal Vaccine Sales Market Share by Region (2016-2021)
Table 6. Global Pneumococcal Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Pneumococcal Vaccine Revenue Share by Region (2016-2021)
Table 8. Global Pneumococcal Vaccine Sales (K Doses) Forecast by Region (2022-2027)
Table 9. Global Pneumococcal Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Pneumococcal Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Pneumococcal Vaccine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Pneumococcal Vaccine Sales (K Doses) of Key Companies (2016-2021)
Table 13. Global Pneumococcal Vaccine Sales Share by Company (2016-2021)
Table 14. Global Pneumococcal Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Pneumococcal Vaccine Revenue Share by Company (2016-2021)
Table 16. Global Pneumococcal Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Vaccine as of 2020)
Table 17. Global Pneumococcal Vaccine Average Price (USD/Dose) of Key Company (2016-2021)
Table 18. Manufacturers Pneumococcal Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Pneumococcal Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Pneumococcal Vaccine Sales (K Doses) by Type (2016-2021)
Table 22. Global Pneumococcal Vaccine Sales Share by Type (2016-2021)
Table 23. Global Pneumococcal Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Pneumococcal Vaccine Price (USD/Dose) by Type (2016-2021)
Table 25. Global Pneumococcal Vaccine Sales Share by Type (2022-2027)
Table 26. Global Pneumococcal Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Pneumococcal Vaccine Revenue Share by Type (2022-2027)
Table 28. Global Pneumococcal Vaccine Price (USD/Dose) by Type (2022-2027)
Table 29. Global Pneumococcal Vaccine Sales (K Doses) by Application (2016-2021)
Table 30. Global Pneumococcal Vaccine Sales Share by Application (2016-2021)
Table 31. Global Pneumococcal Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Pneumococcal Vaccine Price (USD/Dose) by Application (2016-2021)
Table 33. Global Pneumococcal Vaccine Sales (K Doses) by Application (2022-2027)
Table 34. Global Pneumococcal Vaccine Sales Share by Application (2022-2027)
Table 35. Global Pneumococcal Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Pneumococcal Vaccine Revenue Share by Application (2022-2027)
Table 37. Global Pneumococcal Vaccine Price (USD/Dose) by Application (2022-2027)
Table 38. North America Pneumococcal Vaccine Sales (K Doses) by Company (2016-2021)
Table 39. North America Pneumococcal Vaccine Sales Market Share by Company (2016-2021)
Table 40. North America Pneumococcal Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Pneumococcal Vaccine Revenue Market Share by Company (2016-2021)
Table 42. North America Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses)
Table 43. North America Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
Table 44. North America Pneumococcal Vaccine Sales by Type (2022-2027) & (K Doses)
Table 45. North America Pneumococcal Vaccine Sales Market Share by Type (2022-2027)
Table 46. North America Pneumococcal Vaccine Sales by Application (2016-2021) & (K Doses)
Table 47. North America Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Table 48. North America Pneumococcal Vaccine Sales by Application (2022-2027) & (K Doses)
Table 49. North America Pneumococcal Vaccine Sales Market Share by Application (2022-2027)
Table 50. Europe Pneumococcal Vaccine Sales (K Doses) by Company (2016-2021)
Table 51. Europe Pneumococcal Vaccine Sales Market Share by Company (2016-2021)
Table 52. Europe Pneumococcal Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Pneumococcal Vaccine Revenue Market Share by Company (2016-2021)
Table 54. Europe Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses)
Table 55. Europe Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
Table 56. Europe Pneumococcal Vaccine Sales by Type (2022-2027) & (K Doses)
Table 57. Europe Pneumococcal Vaccine Sales Market Share by Type (2022-2027)
Table 58. Europe Pneumococcal Vaccine Sales by Application (2016-2021) & (K Doses)
Table 59. Europe Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Table 60. Europe Pneumococcal Vaccine Sales by Application (2022-2027) & (K Doses)
Table 61. Europe Pneumococcal Vaccine Sales Market Share by Application (2022-2027)
Table 62. China Pneumococcal Vaccine Sales (K Doses) by Company (2016-2021)
Table 63. China Pneumococcal Vaccine Sales Market Share by Company (2016-2021)
Table 64. China Pneumococcal Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Pneumococcal Vaccine Revenue Market Share by Company (2016-2021)
Table 66. China Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses)
Table 67. China Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
Table 68. China Pneumococcal Vaccine Sales by Type (2022-2027) & (K Doses)
Table 69. China Pneumococcal Vaccine Sales Market Share by Type (2022-2027)
Table 70. China Pneumococcal Vaccine Sales by Application (2016-2021) & (K Doses)
Table 71. China Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Table 72. China Pneumococcal Vaccine Sales by Application (2022-2027) & (K Doses)
Table 73. China Pneumococcal Vaccine Sales Market Share by Application (2022-2027)
Table 74. Japan Pneumococcal Vaccine Sales (K Doses) by Company (2016-2021)
Table 75. Japan Pneumococcal Vaccine Sales Market Share by Company (2016-2021)
Table 76. Japan Pneumococcal Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Pneumococcal Vaccine Revenue Market Share by Company (2016-2021)
Table 78. Japan Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses)
Table 79. Japan Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
Table 80. Japan Pneumococcal Vaccine Sales by Type (2022-2027) & (K Doses)
Table 81. Japan Pneumococcal Vaccine Sales Market Share by Type (2022-2027)
Table 82. Japan Pneumococcal Vaccine Sales by Application (2016-2021) & (K Doses)
Table 83. Japan Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Table 84. Japan Pneumococcal Vaccine Sales by Application (2022-2027) & (K Doses)
Table 85. Japan Pneumococcal Vaccine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Pneumococcal Vaccine Sales (K Doses) by Company (2016-2021)
Table 87. Southeast Asia Pneumococcal Vaccine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Pneumococcal Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Pneumococcal Vaccine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses)
Table 91. Southeast Asia Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Pneumococcal Vaccine Sales by Type (2022-2027) & (K Doses)
Table 93. Southeast Asia Pneumococcal Vaccine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Pneumococcal Vaccine Sales by Application (2016-2021) & (K Doses)
Table 95. Southeast Asia Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Pneumococcal Vaccine Sales by Application (2022-2027) & (K Doses)
Table 97. Southeast Asia Pneumococcal Vaccine Sales Market Share by Application (2022-2027)
Table 98. India Pneumococcal Vaccine Sales (K Doses) by Company (2016-2021)
Table 99. India Pneumococcal Vaccine Sales Market Share by Company (2016-2021)
Table 100. India Pneumococcal Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Pneumococcal Vaccine Revenue Market Share by Company (2016-2021)
Table 102. India Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses)
Table 103. India Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
Table 104. India Pneumococcal Vaccine Sales by Type (2022-2027) & (K Doses)
Table 105. India Pneumococcal Vaccine Sales Market Share by Type (2022-2027)
Table 106. India Pneumococcal Vaccine Sales by Application (2016-2021) & (K Doses)
Table 107. India Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Table 108. India Pneumococcal Vaccine Sales by Application (2022-2027) & (K Doses)
Table 109. India Pneumococcal Vaccine Sales Market Share by Application (2022-2027)
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. Pfizer Pneumococcal Vaccine Product
Table 114. Pfizer Recent Development
Table 115. GSK Corporation Information
Table 116. GSK Description and Business Overview
Table 117. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. GSK Pneumococcal Vaccine Product
Table 119. GSK Recent Development
Table 120. MSD Corporation Information
Table 121. MSD Description and Business Overview
Table 122. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. MSD Pneumococcal Vaccine Product
Table 124. MSD Recent Development
Table 125. Sanofipasteur Corporation Information
Table 126. Sanofipasteur Description and Business Overview
Table 127. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. Sanofipasteur Pneumococcal Vaccine Product
Table 129. Sanofipasteur Recent Development
Table 130. CDIBP Corporation Information
Table 131. CDIBP Description and Business Overview
Table 132. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. CDIBP Pneumococcal Vaccine Product
Table 134. CDIBP Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Pneumococcal Vaccine Distributors List
Table 138. Pneumococcal Vaccine Customers List
Table 139. Pneumococcal Vaccine Market Trends
Table 140. Pneumococcal Vaccine Market Drivers
Table 141. Pneumococcal Vaccine Market Challenges
Table 142. Pneumococcal Vaccine Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumococcal Vaccine Product Picture
Figure 2. Global Pneumococcal Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pneumococcal Vaccine Sales Market Share by Application in 2021 & 2027
Figure 6. Child Examples
Figure 7. Adult Examples
Figure 8. Global Pneumococcal Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Pneumococcal Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Pneumococcal Vaccine Sales (K Doses) Growth Rate (2016-2027)
Figure 11. Global Pneumococcal Vaccine Price Trends Growth Rate (2016-2027) (USD/Dose)
Figure 12. Global Pneumococcal Vaccine Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Pneumococcal Vaccine Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Pneumococcal Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Pneumococcal Vaccine Sales (K Doses) Growth Rate (2016-2027)
Figure 16. Europe Pneumococcal Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Pneumococcal Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Pneumococcal Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Pneumococcal Vaccine Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Pneumococcal Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Pneumococcal Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Pneumococcal Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Pneumococcal Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Pneumococcal Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Pneumococcal Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Pneumococcal Vaccine Players Market Share by Revenue in Pneumococcal Vaccine: 2016 & 2020
Figure 27. Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Pneumococcal Vaccine Revenue Share by Type (2016-2021)
Figure 29. Global Pneumococcal Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Pneumococcal Vaccine Revenue Share by Application (2016-2021)
Figure 31. Global Pneumococcal Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Pneumococcal Vaccine Sales Market Share by Type in 2020
Figure 33. North America Pneumococcal Vaccine Sales Market Share by Application in 2020
Figure 34. Europe Pneumococcal Vaccine Sales Market Share by Type in 2020
Figure 35. Europe Pneumococcal Vaccine Sales Market Share by Application in 2020
Figure 36. China Pneumococcal Vaccine Sales Market Share by Type in 2020
Figure 37. China Pneumococcal Vaccine Sales Market Share by Application in 2020
Figure 38. Japan Pneumococcal Vaccine Sales Market Share by Type in 2020
Figure 39. Japan Pneumococcal Vaccine Sales Market Share by Application in 2020
Figure 40. Southeast Asia Pneumococcal Vaccine Sales Market Share by Type in 2020
Figure 41. Southeast Asia Pneumococcal Vaccine Sales Market Share by Application in 2020
Figure 42. India Pneumococcal Vaccine Sales Market Share by Type in 2020
Figure 43. India Pneumococcal Vaccine Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Pneumococcal Vaccine
Figure 46. Manufacturing Process Analysis of Pneumococcal Vaccine
Figure 47. Pneumococcal Vaccine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
7価肺炎球菌ワクチンのグローバル市場調査 2019年 The global 7-Valent Pneumococcal Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on 7-Valent Pneumococcal Vaccine volume and value at global level, regional level and company level. From a glob…- 7価肺炎球菌ワクチンのグローバル市場調査 2019年 The global 7-Valent Pneumococcal Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on 7-Valent Pneumococcal Vaccine volume and value at global level, regional level and company level. From a glob…
- 10価肺炎球菌多糖ワクチンのグローバル市場調査 2019年 The global 10-Valent Pneumococcal Polysaccharide Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on 10-Valent Pneumococcal Polysaccharide Vaccine volume and value at global level, regional leve…
- 10価肺炎球菌多糖ワクチンのグローバル市場調査 2019年 The global 10-Valent Pneumococcal Polysaccharide Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on 10-Valent Pneumococcal Polysaccharide Vaccine volume and value at global level, regional leve…
- 世界の肺炎球菌コンジュゲートワクチン（PCV）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pneumococcal Conjugate Vaccine (PCV) Market The global Pneumococcal Conjugate Vaccine (PCV) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and h…